The Trim32-DPEP2 axis is an inflammatory switch in macrophages during intestinal inflammation

Zhiyan Zhan1,2, Huisheng Liang3,4, Zhuoqi Zhao5

  • 1Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China. zhanzhiyan@sjtu.edu.cn.

PubMed

Insights

Inflammatory macrophages drive intestinal inflammation. Researchers found Dipeptidase-2 (DPEP2) protein degradation by Trim32 activates inflammatory pathways, suggesting the Trim32-DPEP2 axis as a therapeutic target.

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • The precise mechanisms by which inflammatory macrophages contribute to intestinal inflammation remain incompletely understood.
  • Understanding these mechanisms is crucial for developing effective therapeutic strategies for inflammatory bowel diseases.

Purpose of the Study:

  • To elucidate the role of Dipeptidase-2 (DPEP2) in macrophage-mediated intestinal inflammation.
  • To investigate the regulatory axis involving Trim32 and DPEP2 in the context of inflammation.

Main Methods:

  • Integrated analysis of RNA sequencing and mass spectrometry-based quantitative proteomics to compare transcriptomic and proteomic data in activated macrophages.
  • In vivo and in vitro experiments to assess the impact of DPEP2 suppression and degradation on macrophage function and intestinal inflammation.

Main Results:

  • Dipeptidase-2 (DPEP2) protein levels were sharply downregulated in activated macrophages, independent of mRNA levels.
  • Suppression of DPEP2 exacerbated macrophage-mediated intestinal inflammation in vivo and promoted inflammatory pathway activation in vitro.
  • DPEP2 degradation by Trim32 in proinflammatory macrophages led to the activation of NF-κB and p38 MAPK signaling pathways via the release of MAK3K7.

Conclusions:

  • The Trim32-DPEP2 axis plays a critical role in regulating macrophage-mediated intestinal inflammation.
  • DPEP2 acts as a key regulator, with its degradation by Trim32 promoting inflammatory signaling.
  • The Trim32-DPEP2 axis represents a potential therapeutic target for treating intestinal inflammation.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...